Grail logo

Grail Funding & Investors

GRAIL, Inc. operates as a biotechnology company. The Company focuses on combining science, technology, and clinical studies to reveal cancer at its beginings. GRAIL offers its services in the United States.

https://grail.com

Total Amount Raised: $2,004,654,976

Grail Funding Rounds

  • Series D

    $390,000,000

    Series D Investors

    PSP Investments
    Canada Pension Plan Investment Board (CPPIB)
    Illumina
    Huangpu River Capital
  • Series C

    $300,000,000

    Series C Investors

    6 Dimensions Capital
    Ally Bridge Group
    Hillhouse Investment
    Huangpu River Capital
    ICBC International
    Sequoia China
    Blue Pool Capital
    Genuity Science
    China Merchants Securities Co.
  • Series B

    $1,214,655,040

    Series B Investors

    Arch Venture Partners
    Johnson & Johnson Development
    Glen Kacher
    Amino Capital
    The Mark Foundation for Cancer Research
  • Series A

    $100,000,000

    Series A Investors

    Illumina
    Arch Venture Partners
    Bezos Expeditions
    Bill Gates
    Sutter Hill Ventures
    Biomatics Capital Partners
    GV
    Longwood Fund
Funding info provided by Diffbot.